RN7SL248P

Across TCGA pan-cancer cohorts, RN7SL248P Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated RN7SL248P data layer compared with 7 for mass-spec protein.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RN7SL248P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL248P expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

LUSC, LIHC, and BLCA are the cancer types where RN7SL248P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	All	0.171	0.660	.004	33	view →
LIHC	DFS	Median	All	0.044	0.553	<.001	12	view →
BLCA	DFS	Median	III,IV	0.206	0.576	.008	12	view →
UCEC	DFS	Median	II,III,IV	0.922	0.481	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RN7SL248P–LUSC (OS)

Open the LUSC breakdown →